Tygacil Drug Use Investigation

• Status: Completed
• Trial end date: 2017-06-16
• Target enrollment: 0
• Participant gender: All

Summary

Secondary Data Collection Study; safety and effectiveness of Tigecycline .under Japanese medical practice

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer
• Treatments: Minocycline; Tigecycline

Criteria

Inclusion Criteria:

• All patients who are prescribed tigecycline (Tygacil).

Exclusion Criteria:

• Subject who have not been prescribed tigecycline (Tygacil).